| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |